
Precipio PRPO
€ 19.69
-2.44%
Quartalsbericht 2026-Q1
hinzugefügt 14.05.2026
Precipio ROA 2011-2026 | PRPO
ROA Jährlich Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.7 | -25.24 | -32.34 | -56.63 | -27.98 | -51.3 | -67.87 | -72.64 | -75.91 | -604.92 | -684.26 | -46.46 | - | - | - | -9.79 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.7 | -684.26 | -135.16 |
ROA Vierteljährlich Precipio
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.89 | -8.64 | -15.31 | -28.21 | -23.24 | -30.88 | -38.96 | -47.52 | -35.01 | -48.49 | -49.08 | -53.69 | -38.09 | -43.96 | -39.46 | -38.33 | -21.95 | -37.84 | -42.75 | -49.25 | -42.14 | -51.87 | -66.28 | -63.97 | -48.5 | -66.31 | -69.69 | -50.67 | -42.21 | -65.25 | -60.93 | -50.61 | -39.32 | -98.58 | -128.28 | -374.03 | -371.25 | -522.81 | -531.54 | -541.96 | -282.7 | -302.01 | -150.72 | -129.18 | -112.5 | -106.35 | -158.88 | -165.22 | -171.55 | -164.37 | -133.03 | -81.68 | -35.83 | -29.08 | -11.4 | -27.82 | -29.15 | -3.78 | -17.87 | -8.28 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -3.78 | -541.96 | -101.84 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 206.18 | 0.82 % | $ 22.9 B | ||
|
Celcuity
CELC
|
-37.95 | $ 89.53 | -3.31 % | $ 4.19 B | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-189.54 | $ 4.63 | 2.88 % | $ 6.16 M | ||
|
Castle Biosciences
CSTL
|
-4.18 | $ 21.44 | 1.68 % | $ 621 M | ||
|
Fulgent Genetics
FLGT
|
-4.99 | $ 19.12 | 3.35 % | $ 588 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
1.41 | $ 152.76 | 0.62 % | $ 12 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-20.67 | $ 131.71 | 1.22 % | $ 16.5 B | ||
|
Illumina
ILMN
|
12.79 | $ 165.78 | 3.59 % | $ 25.7 B | ||
|
CareDx, Inc
CDNA
|
-5.17 | $ 23.21 | 2.02 % | $ 1.24 B | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
72.63 | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-83.11 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
10.49 | $ 102.44 | 2.46 % | $ 6.91 B | ||
|
Charles River Laboratories International
CRL
|
-2.02 | $ 193.18 | 1.68 % | $ 9.57 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-69.69 | $ 1.42 | 3.28 % | $ 426 M | ||
|
Medpace Holdings
MEDP
|
22.84 | $ 475.39 | 1.84 % | $ 13.7 B | ||
|
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
23.41 | $ 1 162.13 | -0.07 % | $ 24 B | ||
|
NeoGenomics
NEO
|
-7.94 | $ 11.74 | 2.62 % | $ 1.5 B | ||
|
Myriad Genetics
MYGN
|
-51.8 | $ 4.66 | 2.53 % | $ 432 M | ||
|
National Research Corporation
NRC
|
8.6 | $ 20.98 | 6.23 % | $ 470 M | ||
|
Natera
NTRA
|
-8.68 | $ 222.41 | -0.19 % | $ 30.4 B | ||
|
Personalis
PSNL
|
-24.32 | $ 10.26 | 5.23 % | $ 916 M | ||
|
Koninklijke Philips N.V.
PHG
|
3.33 | $ 25.84 | -2.49 % | $ 24.5 B | ||
|
Senseonics Holdings
SENS
|
-54.72 | $ 7.65 | 2.9 % | $ 319 M | ||
|
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 274.38 | 1.17 % | $ 22.8 B | ||
|
Thermo Fisher Scientific
TMO
|
6.08 | $ 492.63 | -0.34 % | $ 186 B | ||
|
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.68 | 2.39 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
-12.1 | $ 70.12 | 0.09 % | $ 4.19 B | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 9.32 | 0.38 % | $ 2.02 B | ||
|
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M |